These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30897972)

  • 1. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
    Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
    Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
    Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
    Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy and breast cancer: focus on angiogenesis.
    Varinska L; Gal P; Mojzisova G; Mirossay L; Mojzis J
    Int J Mol Sci; 2015 May; 16(5):11728-49. PubMed ID: 26006245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavones and cancer prevention.
    Sarkar FH; Li Y
    Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.
    Hillman GG
    Semin Radiat Oncol; 2019 Jan; 29(1):62-71. PubMed ID: 30573186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
    Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
    Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
    Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
    Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy for breast cancer survivors: a critical review of the literature.
    Messina MJ; Loprinzi CL
    J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone.
    Li HQ; Luo Y; Qiao CH
    Mini Rev Med Chem; 2012 Apr; 12(4):350-62. PubMed ID: 22303948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
    Takimoto CH; Glover K; Huang X; Hayes SA; Gallot L; Quinn M; Jovanovic BD; Shapiro A; Hernandez L; Goetz A; Llorens V; Lieberman R; Crowell JA; Poisson BA; Bergan RC
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1213-21. PubMed ID: 14652284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
    Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
    Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.
    Singh-Gupta V; Joiner MC; Runyan L; Yunker CK; Sarkar FH; Miller S; Gadgeel SM; Konski AA; Hillman GG
    J Thorac Oncol; 2011 Apr; 6(4):688-98. PubMed ID: 21325978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy Isoflavones and their Effects on Xenobiotic Metabolism.
    Zhou T; Meng C; He P
    Curr Drug Metab; 2019; 20(1):46-53. PubMed ID: 29708073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes.
    Davis JN; Kucuk O; Djuric Z; Sarkar FH
    Free Radic Biol Med; 2001 Jun; 30(11):1293-302. PubMed ID: 11368927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways.
    Li Y; Kong D; Bao B; Ahmad A; Sarkar FH
    Nutrients; 2011 Oct; 3(10):877-96. PubMed ID: 22200028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.